Metraipolis › archive › dc_507033985804

CDAI trajectories in patients with rheumatoid arthritis treated with abatacept in real-world — Europe PMC PMID:42337779

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42337779
DOI
10.1186/s42358-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-10-19T05:51:15.595Z
SHA-256 of the archived text
3f6b4514d44f37e6955b9d83bce3febd71d0ef0bec9f8ca9f2355e9ffd455495
Stable URL of this page
https://metraipolis.com/documento/dc_507033985804

How to cite

CDAI trajectories in patients with rheumatoid arthritis treated with abatacept in real-world — Europe PMC PMID:42337779 — Europe PMC (en), https://europepmc.org/article/MED/42337779 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_507033985804 (Metraipolis archive dc_507033985804, sha256 3f6b4514d44f37e6955b9d83bce3febd71d0ef0bec9f8ca9f2355e9ffd455495)
BibTeX
@misc{dc507033985804,
  title = {CDAI trajectories in patients with rheumatoid arthritis treated with abatacept in real-world — Europe PMC PMID:42337779},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42337779},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_507033985804; sha256 3f6b4514d44f37e6955b9d83bce3febd71d0ef0bec9f8ca9f2355e9ffd455495},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42337779. Agents can read the archived copy with the MCP tool read_document.